JENNIFER WRIGHT: Open Payments
NPI 1568943942 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 95 payments from 13 companies in 2025. Trend: 2023 $56 · 2024 $359 · 2025 $1,764
Food & beverage: $1,759Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $293 |
| Incyte Corporation | 9 | $241 |
| Regeneron Healthcare Solutions, Inc. | 8 | $215 |
| GENZYME CORPORATION | 7 | $197 |
| Galderma Laboratories, L.P. | 12 | $181 |
| Janssen Biotech, Inc. | 8 | $149 |
| Lilly USA, LLC | 10 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $73 |
| Organon LLC | 4 | $71 |
Products named: DUPIXENT, OPZELURA, NEMLUVIO, SKYRIZI, TREMFYA, RINVOQ, TALTZ, EBGLYSS.
Industry payments across DE — which companies pay providers there.
